<SEC-DOCUMENT>0001513162-22-000014.txt : 20220210
<SEC-HEADER>0001513162-22-000014.hdr.sgml : 20220210
<ACCEPTANCE-DATETIME>20220210160417
ACCESSION NUMBER:		0001513162-22-000014
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20220208
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220210
DATE AS OF CHANGE:		20220210

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BIOMERICA INC
		CENTRAL INDEX KEY:			0000073290
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		IRS NUMBER:				952645573
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0531

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37863
		FILM NUMBER:		22613856

	BUSINESS ADDRESS:	
		STREET 1:		17571 VON KARMAN AVENUE
		CITY:			IRVINE
		STATE:			CA
		ZIP:			92614
		BUSINESS PHONE:		9496452111

	MAIL ADDRESS:	
		STREET 1:		17571 VON KARMAN AVENUE
		CITY:			IRVINE
		STATE:			CA
		ZIP:			92614

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NMS PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	19871130

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NUCLEAR MEDICAL SYSTEMS INC
		DATE OF NAME CHANGE:	19830216

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NUCLEAR INSTRUMENTS INC
		DATE OF NAME CHANGE:	19720508
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>bmra-20220208.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Thu Feb 10 08:37:40 UTC 2022 -->
<html xmlns:bmra="http://www.biomerica.com/20220208" xmlns:compsci="http://compsciresources.com" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:us-types="http://fasb.org/us-types/2021-01-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.w3.org/1999/xhtml" xmlns:xml="http://www.w3.org/XML/1998/namespace"><head><title>Form 8-K</title>
<meta content="text/html" http-equiv="Content-Type" />
</head> <body><div> </div><div style="page:WordSection1"> <a id="_Hlk58520919"></a><a id="Form_8_K"></a><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:174%; text-align: center;"><b><span style="FONT-SIZE:14pt; LINE-HEIGHT:174%">UNITED STATES</span></b></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:174%; text-align: center;"><b><span style="FONT-SIZE:14pt; LINE-HEIGHT:174%">SECURITIES AND EXCHANGE COMMISSION</span></b></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:174%; text-align: center;"><b><span style="FONT-SIZE:12pt; LINE-HEIGHT:174%">WASHINGTON, DC 20549</span></b></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:174%; text-align: center;"><span style="FONT-SIZE:12pt; LINE-HEIGHT:174%">_______________</span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:12pt 0cm 0pt; LINE-HEIGHT:174%; text-align: center;"><b><span style="FONT-SIZE:16pt; LINE-HEIGHT:174%">FORM <ix:nonNumeric contextRef="c0" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:12pt 0cm 0pt; LINE-HEIGHT:174%; text-align: center;"><b><span style="FONT-SIZE:12pt; LINE-HEIGHT:174%">CURRENT REPORT</span></b></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><b><span style="FONT-SIZE:12pt">Pursuant to Section 13 or 15(d) of the</span></b></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:174%; text-align: center;"><b><span style="FONT-SIZE:12pt; LINE-HEIGHT:174%">Securities Exchange Act of 1934</span></b></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:6pt 0cm 0pt; text-align: center;"><span style="FONT-SIZE:11pt">Date of Report (Date of earliest event reported):<b>&#160; <ix:nonNumeric contextRef="c0" format="ixt:date-monthname-day-year-en" name="dei:DocumentPeriodEndDate">February 8, 2022</ix:nonNumeric></b></span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:12pt 0cm 0pt; text-align: center;"><ix:nonNumeric contextRef="c0" name="dei:EntityRegistrantName"><b><span style="FONT-SIZE:20pt">BIOMERICA, INC.</span></b></ix:nonNumeric></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 12pt; text-align: center;"><span>(Exact name of registrant as specified in its charter)</span></p> <div style="text-align: center;"> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:collapse; margin-left: auto; margin-right: auto;" width="696"> <tr style="HEIGHT:13pt"> <td style="BORDER-TOP:0px; HEIGHT:13pt; BORDER-RIGHT:0px; WIDTH:174pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:3pt; BORDER-LEFT:0px; PADDING-RIGHT:3pt"> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; PAGE-BREAK-AFTER:none; TEXT-ALIGN:center; MARGIN:2pt 0cm; text-align: center;"><ix:nonNumeric contextRef="c0" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode"><b><span style="COLOR:black">Delaware</span></b></ix:nonNumeric></p></td> <td style="BORDER-TOP:0px; HEIGHT:13pt; BORDER-RIGHT:0px; WIDTH:174pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:3pt; BORDER-LEFT:0px; PADDING-RIGHT:3pt"> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; PAGE-BREAK-AFTER:none; TEXT-ALIGN:center; MARGIN:2pt 0cm; text-align: center;"><ix:nonNumeric contextRef="c0" name="dei:EntityFileNumber"><b><span style="COLOR:black">001-37863</span></b></ix:nonNumeric></p></td> <td style="BORDER-TOP:0px; HEIGHT:13pt; BORDER-RIGHT:0px; WIDTH:174pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:3pt; BORDER-LEFT:0px; PADDING-RIGHT:3pt"> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; PAGE-BREAK-AFTER:none; TEXT-ALIGN:center; MARGIN:2pt 0cm; text-align: center;"><ix:nonNumeric contextRef="c0" name="dei:EntityTaxIdentificationNumber"><b><span style="COLOR:black">95-2645573</span></b></ix:nonNumeric></p></td></tr> <tr style="HEIGHT:26pt"> <td style="HEIGHT:26pt; WIDTH:174pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign="bottom"> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:2pt 0cm; text-align: center;"><span>(State or Other Jurisdiction</span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:2pt 0cm; text-align: center;"><span>of Incorporation)</span></p></td> <td style="HEIGHT:26pt; WIDTH:174pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign="bottom"> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:2pt 0cm; text-align: center;"><span>(Commission</span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:2pt 0cm; text-align: center;"><span>File Number)</span></p></td> <td style="HEIGHT:26pt; WIDTH:174pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign="bottom"> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:2pt 0cm; text-align: center;"><span>(IRS Employer</span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:2pt 0cm; text-align: center;"><span>Identification No.)</span></p></td></tr></table></div> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:6pt 0cm 14pt">&#160;</p> <div style="text-align: center;"> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:collapse; margin-left: auto; margin-right: auto;" width="696"> <tr style="HEIGHT:13pt"> <td style="BORDER-TOP:0px; HEIGHT:13pt; BORDER-RIGHT:0px; WIDTH:67pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:3pt; BORDER-LEFT:0px; PADDING-RIGHT:0cm" valign="bottom"> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; PAGE-BREAK-AFTER:none; MARGIN:2pt 0cm">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:13pt; BORDER-RIGHT:0px; WIDTH:388pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:3pt; BORDER-LEFT:0px; PADDING-RIGHT:3pt" valign="bottom"> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; PAGE-BREAK-AFTER:none; TEXT-ALIGN:center; MARGIN:2pt 0cm; text-align: center;"><b><span style="COLOR:black"><ix:nonNumeric contextRef="c0" name="dei:EntityAddressAddressLine1">17571 Von Karman Ave</ix:nonNumeric>. <ix:nonNumeric contextRef="c0" name="dei:EntityAddressCityOrTown">Irvine</ix:nonNumeric>, <ix:nonNumeric contextRef="c0" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince">California</ix:nonNumeric></span></b></p></td> <td style="BORDER-TOP:0px; HEIGHT:13pt; BORDER-RIGHT:0px; WIDTH:67pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:3pt; BORDER-LEFT:0px; PADDING-RIGHT:3pt" valign="bottom"> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; PAGE-BREAK-AFTER:none; TEXT-ALIGN:center; MARGIN:2pt 0cm; text-align: center;"><ix:nonNumeric contextRef="c0" name="dei:EntityAddressPostalZipCode"><b><span style="COLOR:black">92614</span></b></ix:nonNumeric></p></td></tr> <tr style="HEIGHT:14pt"> <td style="HEIGHT:14pt; WIDTH:67pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:3pt; PADDING-RIGHT:0cm" valign="bottom"> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:2pt 0cm">&#160;</p></td> <td style="HEIGHT:14pt; WIDTH:388pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:3pt; PADDING-RIGHT:3pt"> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:2pt 0cm; text-align: center;"><span style="COLOR:black">(Address of Principal Executive Offices)</span></p></td> <td style="HEIGHT:14pt; WIDTH:67pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:3pt; PADDING-RIGHT:3pt"> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:2pt 0cm; text-align: center;"><span style="COLOR:black">(Zip Code)</span></p></td></tr></table></div> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:12pt 0cm 0pt; text-align: center;"><span>Registrant&#8217;s telephone number, including area code:&#160; <b>(<ix:nonNumeric contextRef="c0" name="dei:CityAreaCode">949</ix:nonNumeric>) <ix:nonNumeric contextRef="c0" name="dei:LocalPhoneNumber">645-2111</ix:nonNumeric></b></span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:12pt 0cm 0pt; LINE-HEIGHT:174%; text-align: center;"><b><span style="COLOR:black">Not Applicable</span></b></p> <br/><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:174%; text-align: center;"><span>(Former name or former address if changed since last report)</span></p><br/> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><span>Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:12pt 0cm 0pt"><ix:nonNumeric contextRef="c0" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications"><span style="FONT-SIZE:12pt"><span>&#9744;</span></span></ix:nonNumeric><span>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)<br/>&#160;</span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><ix:nonNumeric contextRef="c0" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial"><span style="FONT-SIZE:12pt; ">&#9744;</span></ix:nonNumeric><span>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)<br/>&#160;</span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><ix:nonNumeric contextRef="c0" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer"><span style="FONT-SIZE:12pt; ">&#9744;</span></ix:nonNumeric><span>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))<br/>&#160;</span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt"><ix:nonNumeric contextRef="c0" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer"><span style="FONT-SIZE:12pt; ">&#9744;</span></ix:nonNumeric><span>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:120%">&#160;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt">Securities registered pursuant to Section 12(b) of the Act:</span></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p> <table cellpadding="0" cellspacing="0" style="WIDTH:65%; BORDER-COLLAPSE:collapse" width="65%"> <tr> <td style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:36%; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; width: 36%;" valign="top"> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><b><span>Title of each class</span></b></p></td> <td style="WIDTH:2%; PADDING-BOTTOM:1.5pt; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%;" valign="top"> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;">&#160;</p></td> <td style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:20%; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; width: 20%;" valign="top"> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><b><span>Trading Symbol(s)</span></b></p></td> <td style="WIDTH:2%; PADDING-BOTTOM:1.5pt; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm; width: 2%;" valign="top"> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;">&#160;</p></td> <td style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:40%; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm; width: 40%;" valign="top"> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><b><span>Name of each exchange on which registered</span></b></p></td></tr> <tr> <td style="PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm" valign="top"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><ix:nonNumeric contextRef="c0" name="dei:Security12bTitle"><span style="FONT-SIZE:10pt">Common Stock, par value $0.08</span></ix:nonNumeric></p></td> <td style="PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm" valign="top"> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;">&#160;</p></td> <td style="PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm" valign="top"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><ix:nonNumeric contextRef="c0" name="dei:TradingSymbol"><span style="FONT-SIZE:10pt">BMRA</span></ix:nonNumeric></p></td> <td style="PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm" valign="top"> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;">&#160;</p></td> <td style="PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm" valign="top"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt">The <ix:nonNumeric contextRef="c0" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric> Stock Market LLC</span></p></td></tr></table> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:120%">&#160;</p> <p style="FONT-SIZE:10pt; TEXT-ALIGN:justify;FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0pt 0pt 0cm; LINE-HEIGHT:120%"><span>Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).&#160;&#160; Emerging growth company&#160;&#160;&#160;&#160;&#160; </span><ix:nonNumeric contextRef="c0" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany"><span>&#9744;</span></ix:nonNumeric></p> <p style="FONT-SIZE:10pt; TEXT-ALIGN:justify;FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:12pt 0pt 0pt 0cm; LINE-HEIGHT:120%"><span>If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;&#160; </span><span>&#9744;</span></p></div><div><span style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; LINE-HEIGHT:120%"><span style="PAGE-BREAK-BEFORE:none; clear: both;"><br/></span></span></div><div> </div><div style="page:WordSection2"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">1</span></p> <div style="BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><div style="FONT-SIZE:10pt; COLOR:black"> <hr/> <div style="PAGE-BREAK-BEFORE: always"></div> </div></div> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;">&#160;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><b><span style="FONT-SIZE:10pt; COLOR:black">Item 7.01 &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Regulation FD Disclosure.</span></b></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">On February 8, 2022, Biomerica, Inc. (the &#8220;Company&#8221;) issued a&#160;press&#160;release&#160;regarding the&#160;results&#160;from the endpoint clinical trial of its InFoods<sup>&#174; </sup>IBS Treatment for patients with Irritable Bowel Syndrome.&#160; The full text of the&#160;press&#160;release&#160;is attached as Exhibit 99.1 to this Current Report on Form&#160;8-K.</span></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; BACKGROUND:white; COLOR:black">The information provided under this Item 7.01, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that section. Such information shall not be deemed incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as otherwise expressly set forth by specific reference in such filing.</span></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p>  <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><b><span style="FONT-SIZE:10pt; COLOR:black">Item 8.01 &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Other Events.</span></b></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt"><span style="FONT-SIZE:10pt; COLOR:black">On February 8, 2022, the Company issued a&#160;press&#160;release&#160;regarding the&#160;results&#160;from the endpoint clinical trial of its InFoods<sup>&#174; </sup>IBS Treatment for patients with Irritable Bowel Syndrome.&#160; </span></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:5pt 0cm"><span style="COLOR:black">The InFoods&#174; IBS endpoint trial was run at several medical institutions including Mayo Clinic, Beth Israel Deaconess Medical Center Inc., a Harvard Medical School Teaching Hospital, Houston Methodist Hospital and the University of Michigan. Multiple endpoints demonstrated statistically significant improvements, indicating that the elimination of specific foods may meaningfully reduce the symptoms of IBS in all subtypes (the clinical study included patients with IBS-Constipation, IBS-Diarrhea &amp; IBS-Mixed).&#160; The greatest clinical improvements were seen in patients diagnosed with IBS-Mixed and IBS-Constipation.&#160; The Company plans to meet with the FDA to review these results and finalize a pivotal trial for FDA clearance. Highlights of select topline results from the InFoods&#174; IBS endpoint trial were:<br/>&#160;<br/></span></p> <a id="_Hlk94707612"></a><a id="_Hlk95316254"></a><ul style="MARGIN-BOTTOM:0cm; MARGIN-TOP:0cm; list-style-type: disc;"> <li style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; BACKGROUND:white; COLOR:black; MARGIN:5pt 0cm"><span>P-value of 0.007 for improvement in the Subject Global Assessment of Relief (SGA) endpoint for all patient subtypes as a group (baseline vs 8 weeks)</span> </li><li style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; BACKGROUND:white; COLOR:black; MARGIN:5pt 0cm"><span>P-value of 0.040 for improvement in the Global Improvement Scale (GIS) endpoint for all patient subtypes as a group (baseline vs 8 weeks)</span> </li><li style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; BACKGROUND:white; COLOR:black; MARGIN:5pt 0cm"><span>P-value of 0.012 for improvement in the Abdominal Pain Intensity (IBS-API) endpoint for IBS-Mixed &amp; IBS-Constipation patients as a group (baseline vs 8 weeks)</span> </li><li style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; BACKGROUND:white; COLOR:black; MARGIN:5pt 0cm"><span>P-value of 0.022 for improvement in the Bloating endpoint for IBS-Mixed &amp; IBS-Constipation patients as a group (baseline vs 8 weeks)</span> </li></ul> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; BACKGROUND:white; MARGIN:0cm 0cm 12pt"><b><span style="COLOR:black">Item&#160;9.01&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Financial Statements and Exhibits.</span></b></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 12pt 36pt; TEXT-INDENT:-18pt"><span style="FONT-SIZE:10pt">(d) &#160; Exhibits. </span></p> <table cellpadding="0" cellspacing="0" style="WIDTH:550pt; BORDER-COLLAPSE:collapse" width="733"> <tr> <td style="WIDTH:9.26%; PADDING-BOTTOM:0cm; PADDING-TOP:0.7pt; PADDING-LEFT:0cm; PADDING-RIGHT:0.7pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; PAGE-BREAK-AFTER:none; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:100%; text-align: center;"><span style="FONT-SIZE:10pt; LINE-HEIGHT:100%">&#160;</span><b><span style="text-decoration:underline"><span style="FONT-SIZE:10pt; LINE-HEIGHT:100%">Number</span></span></b></p></td> <td style="WIDTH:1.08%; PADDING-BOTTOM:0cm; PADDING-TOP:0.7pt; PADDING-LEFT:0cm; PADDING-RIGHT:0.7pt" valign="bottom"> <p style="FONT-SIZE:4pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:100%"><span style="FONT-SIZE:10pt; LINE-HEIGHT:100%">&#160;&#160;</span></p></td> <td style="WIDTH:89.66%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; PAGE-BREAK-AFTER:none; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:100%"><b><span style="text-decoration:underline"><span style="FONT-SIZE:10pt; LINE-HEIGHT:100%">Description</span></span></b></p></td></tr> <tr> <td style="WIDTH:9.26%; PADDING-BOTTOM:0cm; PADDING-TOP:0.7pt; PADDING-LEFT:0cm; PADDING-RIGHT:0.7pt" valign="top"> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:100%">&#160;</p></td> <td style="WIDTH:1.08%; PADDING-BOTTOM:0cm; PADDING-TOP:0.7pt; PADDING-LEFT:0cm; PADDING-RIGHT:0.7pt" valign="bottom"> <p style="FONT-SIZE:4pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:100%">&#160;</p></td> <td style="WIDTH:89.66%; PADDING-BOTTOM:0cm; PADDING-TOP:0.7pt; PADDING-LEFT:0cm; PADDING-RIGHT:0.7pt" valign="top"> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:100%">&#160;</p></td></tr> <tr> <td style="WIDTH:9.26%; PADDING-BOTTOM:0cm; PADDING-TOP:0.7pt; PADDING-LEFT:0cm; PADDING-RIGHT:0pt" valign="top"> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;;TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:100%"><span>99.1</span></p></td> <td style="WIDTH:1.08%; PADDING-BOTTOM:0cm; PADDING-TOP:0.7pt; PADDING-LEFT:0cm; PADDING-RIGHT:0.7pt" valign="bottom"> <p style="FONT-SIZE:4pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:100%">&#160;</p></td> <td style="WIDTH:89.66%; PADDING-BOTTOM:0cm; PADDING-TOP:0.7pt; PADDING-LEFT:0cm; PADDING-RIGHT:0.7pt" valign="top"> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0pt 0pt 0cm; LINE-HEIGHT:100%"><span>Press Release of Biomerica, Inc., issued February 8, 2022.</span></p></td></tr></table> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt">&#160;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">2</span></p> <div style="BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><div style="FONT-SIZE:10pt; COLOR:black"> <hr/> <div style="PAGE-BREAK-BEFORE: always"></div> </div></div> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; PAGE-BREAK-BEFORE:none; TEXT-ALIGN:center; MARGIN:11.25pt 0cm 0pt; LINE-HEIGHT:120%; text-align: center;"><b><span>SIGNATURE</span></b></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:7.5pt 0cm 0pt; LINE-HEIGHT:120%; TEXT-INDENT:23pt"><span>Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 7pt">&#160;</p> <table cellpadding="0" cellspacing="0" style="width: 538.5pt; border-collapse: collapse;" width="718">

<tr style="height: 15pt;">
<td style="height: 15pt; width: 50%; padding: 0cm;" valign="bottom">
<p style="font-size: 10pt; font-family: 'Times New Roman','serif'; page-break-after: none; margin: 2pt 0cm;">&#160;</p>
</td>
<td colspan="2" style="height: 15pt; width: 47%; padding: 0cm;" valign="bottom">
<p style="font-size: 10pt; font-family: 'Times New Roman','serif'; page-break-after: none; margin: 2pt 0cm;"><strong><span style="color: black;">BIOMERICA, INC.</span></strong></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 50%; padding: 0cm;" valign="bottom">
<p style="font-size: 10pt; font-family: 'Times New Roman','serif'; page-break-after: none; margin: 2pt 0cm;">&#160;</p>
</td>
<td style="height: 15pt; width: 3%; padding: 0cm;" valign="bottom">
<p style="font-size: 10pt; font-family: 'Times New Roman','serif'; page-break-after: none; margin: 2pt 0cm;">&#160;</p>
</td>
<td style="height: 15pt; width: 47%; padding: 0cm;" valign="bottom">
<p style="font-size: 10pt; font-family: 'Times New Roman','serif'; page-break-after: none; margin: 2pt 0cm;">&#160;</p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 50%; padding: 0cm 2pt 0cm 0cm;" valign="bottom">
<p style="font-size: 10pt; font-family: 'Times New Roman','serif'; page-break-after: none; margin: 2pt 0cm;"><span style="color: black;">Date:&#160; February 10, 2022</span></p>
</td>
<td style="height: 15pt; width: 3%; padding: 0cm 2pt 0cm 0cm;" valign="bottom">
<p style="font-size: 10pt; font-family: 'Times New Roman','serif'; page-break-after: none; margin: 2pt 0cm;"><span style="color: black;">By:</span></p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 47%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0cm 2pt 0cm 0cm;" valign="bottom">
<p style="font-size: 10pt; font-family: 'Times New Roman','serif'; page-break-after: none; margin: 2pt 0cm;"><span style="color: black;">/s/ Zackary S. Irani</span></p>
</td>
</tr>
<tr style="height: 14.4pt;">
<td style="height: 14.4pt; width: 50%; padding: 0cm;" valign="bottom">
<p style="font-size: 10pt; font-family: 'Times New Roman','serif'; margin: 2pt 0cm;">&#160;</p>
</td>
<td style="height: 14.4pt; width: 3%; padding: 0cm;" valign="bottom">
<p style="font-size: 10pt; font-family: 'Times New Roman','serif'; margin: 2pt 0cm;">&#160;</p>
</td>
<td style="height: 14.4pt; width: 47%; padding: 0cm 2pt 0cm 0cm;" valign="bottom">
<p style="font-size: 10pt; font-family: 'Times New Roman','serif'; margin: 2pt 0cm;"><span style="color: black;">Zackary S. Irani<br/>Chief Executive Officer</span></p>
</td>
</tr>

</table> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0cm 0cm 7pt">&#160;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">3</span></p></div><div>
</div><!-- EDGAR Validation Code: BFA03F28 --><div>

</div><div style="display: none"><ix:header>
<ix:hidden>
<ix:nonNumeric contextRef="c0" name="dei:AmendmentFlag">false</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:EntityCentralIndexKey">0000073290</ix:nonNumeric>
</ix:hidden>
<ix:references><link:schemaRef xlink:href="bmra-20220208.xsd" xlink:type="simple"></link:schemaRef></ix:references>
<ix:resources xmlns="http://www.xbrl.org/2003/instance"><xbrli:context id="c0">
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt+1Vq3zhhUlfDeP/RQUzUZihDO8dLtQrMZMNe4t6pAivP0axfdFZpsLFQssGmBLplGse/UzOMFuCKnvfJVYCksmPg85G6fX8Y7kwAP+0ldS7Ne4aheVzICxDvuLjIh2SkXUzCTjZAzKPXvyqE1gFxbYpupTAeZjEYLwWiqji4gQLTBEPZDqJIsv9b6nWaf5QPk=] CSR-->
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-02-08</xbrli:startDate>
    <xbrli:endDate>2022-02-08</xbrli:endDate>
  </xbrli:period>
</xbrli:context></ix:resources></ix:header>

</div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>2
<FILENAME>bmra-20220208.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Thu Feb 10 08:37:40 UTC 2022 -->
<xs:schema xmlns:bmra="http://www.biomerica.com/20220208" elementFormDefault="qualified" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" targetNamespace="http://www.biomerica.com/20220208" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:us-types="http://fasb.org/us-types/2021-01-31" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dtr="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="bmra-20220208_lab.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="bmra-20220208_pre.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="bmra-20220208_def.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef"/>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt+1Vq3zhhUlfDeP/RQUzUZihDO8dLtQrMZMNe4t6pAivP0axfdFZpsLFQssGmBLplGse/UzOMFuCKnvfJVYCksmPg85G6fX8Y7kwAP+0ldS7Ne4aheVzICxDvuLjIh2SkXUzCTjZAzKPXvyqE1gFxbYpupTAeZjEYLwWiqji4gQLe87jPL0j6lLuYuIecOPx7k=] CSR-->
      <link:roleType roleURI="http://www.biomerica.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000 - Document - Document And Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://fasb.org/srt-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/sic/2021" schemaLocation="https://xbrl.sec.gov/sic/2021/sic-2021.xsd"/>
  <xs:element name="DocumentAndEntityInformationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_DocumentAndEntityInformationAbstract"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>3
<FILENAME>bmra-20220208_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Thu Feb 10 08:37:40 UTC 2022 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <roleRef xlink:type="simple" xlink:href="bmra-20220208.xsd#DocumentAndEntityInformation" roleURI="http://www.biomerica.com/role/DocumentAndEntityInformation"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all"/>
  <definitionLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/DocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentInformationLineItems"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentInformationTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="8" xbrldt:closed="true"/>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt+1Vq3zhhUlfDeP/RQUzUZihDO8dLtQrMZMNe4t6pAivP0axfdFZpsLFQssGmBLplGse/UzOMFuCKnvfJVYCksmPg85G6fX8Y7kwAP+0ldS7Ne4aheVzICxDvuLjIh2SkXUzCTjZAzKPXvyqE1gFxbYpupTAeZjEYLwWiqji4gQLcFdxJXqWQUih37DjNAePss=] CSR-->
    <loc xlink:type="locator" xlink:label="dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_WrittenCommunications" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SolicitingMaterial" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" order="22" xbrldt:closed="true"/>
  </definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>bmra-20220208_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Thu Feb 10 08:37:40 UTC 2022 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl"/>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt+1Vq3zhhUlfDeP/RQUzUZihDO8dLtQrMZMNe4t6pAivP0axfdFZpsLFQssGmBLplGse/UzOMFuCKnvfJVYCksmPg85G6fX8Y7kwAP+0ldS7Ne4aheVzICxDvuLjIh2SkXUzCTjZAzKPXvyqE1gFxbYpupTAeZjEYLwWiqji4gQLXq+8wRXxF1v9VqqSPDxLpI=] CSR-->
    <loc xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl0" xml:lang="en-US">Entity File Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl0" xml:lang="en-US">Entity Emerging Growth Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl0" xml:lang="en-US">Entity Address, City or Town</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl0" xml:lang="en-US">Entity Tax Identification Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl0" xml:lang="en-US">Entity Address, Postal Zip Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl0" xml:lang="en-US">Document Type</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl0" xml:lang="en-US">City Area Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl0" xml:lang="en-US">Document Period End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl0" xml:lang="en-US">Amendment Flag</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl0" xml:lang="en-US">Entity Address, State or Province</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl0" xml:lang="en-US">Trading Symbol</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl0" xml:lang="en-US">Pre-commencement Tender Offer</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl0" xml:lang="en-US">Title of 12(b) Security</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl0" xml:lang="en-US">Written Communications</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl0" xml:lang="en-US">Soliciting Material</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl0" xml:lang="en-US">Entity Central Index Key</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl0" xml:lang="en-US">Local Phone Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl0" xml:lang="en-US">Entity Incorporation, State or Country Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl0" xml:lang="en-US">Security Exchange Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl0" xml:lang="en-US">Entity Address, Address Line One</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl0" xml:lang="en-US">Pre-commencement Issuer Tender Offer</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl0" xml:lang="en-US">Entity Registrant Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_StatementScenarioAxis_lbl" xml:lang="en-US">Scenario [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_StatementScenarioAxis_lbl"/>
  </labelLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>bmra-20220208_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Thu Feb 10 08:37:40 UTC 2022 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="bmra-20220208.xsd#DocumentAndEntityInformation" roleURI="http://www.biomerica.com/role/DocumentAndEntityInformation"/>
  <presentationLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/DocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:label="DocumentAndEntityInformationAbstract" xlink:href="bmra-20220208.xsd#bmra_DocumentAndEntityInformationAbstract"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentInformationTable"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentInformationLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentInformationTable" order="1.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationLineItems" order="1.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt+1Vq3zhhUlfDeP/RQUzUZihDO8dLtQrMZMNe4t6pAivP0axfdFZpsLFQssGmBLplGse/UzOMFuCKnvfJVYCksmPg85G6fX8Y7kwAP+0ldS7Ne4aheVzICxDvuLjIh2SkXUzCTjZAzKPXvyqE1gFxbYpupTAeZjEYLwWiqji4gQLSjKFV70ZaKOTQfRAxK1hyY=] CSR-->
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_WrittenCommunications" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SolicitingMaterial" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>6
<FILENAME>exhibit99_1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<head><title>Exhibit 99.1</title> </head> <body vlink=purple link=blue lang=EN-IN> <div style=page:WordSection1> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:windowtext; TEXT-ALIGN:justify; MARGIN:0cm 0cm 6pt' align=center><img width=693 height=75 style="HEIGHT:75px; WIDTH:1097px" src=logo.jpg></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:windowtext; TEXT-ALIGN:justify; MARGIN:0cm 0cm 6pt'><b><font style='FONT-SIZE:13pt; FONT-FAMILY:"Verdana","sans-serif"; COLOR:#002c40' lang=EN-US>Biomerica Announces Positive Topline Results from the Endpoint Clinical Trial of its InFoods<sup>&#174;</sup> IBS Treatment for Patients with Irritable Bowel Syndrome</font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:windowtext; MARGIN:0cm 0cm 6pt'><b></b>&nbsp;</p> <ul type=disc style="MARGIN-BOTTOM:0cm; MARGIN-TOP:0cm"> <li style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; COLOR:#002c40; TEXT-ALIGN:justify; MARGIN:5pt 0cm'><b><font style='FONT-SIZE:11pt; FONT-FAMILY:"Arial","sans-serif"' lang=EN-US>InFoods&#174;&nbsp;IBS Diagnostic-Guided Therapy is the first therapy of its kind using science, diet and technology to identify patient specific foods, which when eliminated, help reduce the symptoms of IBS without the use of drugs</font></b> <li style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; COLOR:#002c40; TEXT-ALIGN:justify; MARGIN:5pt 0cm'><b><font style='FONT-SIZE:11pt; FONT-FAMILY:"Arial","sans-serif"' lang=EN-US>Multiple endpoints demonstrated statistically significant improvements, indicating that the elimination of specific foods may meaningfully reduce the symptoms of IBS in all subtypes (clinical study included patients with IBS-Constipation, IBS-Diarrhea &amp; IBS-Mixed) </font></b> <li style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; COLOR:#002c40; TEXT-ALIGN:justify; MARGIN:5pt 0cm'><b><font style='FONT-SIZE:11pt; FONT-FAMILY:"Arial","sans-serif"' lang=EN-US>Greatest clinical improvements, including but not limited to pain and bloating, were seen in patients diagnosed with IBS-Mixed and IBS-Constipation</font></b> <li style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; COLOR:#002c40; TEXT-ALIGN:justify; MARGIN:5pt 0cm'><b><font style='FONT-SIZE:11pt; FONT-FAMILY:"Arial","sans-serif"' lang=EN-US>The InFoods&#174; IBS trial was run at leading medical institutions including Mayo Clinic, Beth Israel Deaconess Medical Center Inc., a Harvard Medical School Teaching Hospital, Houston Methodist Hospital and the University of Michigan&nbsp; </font></b> <li style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; COLOR:#002c40; TEXT-ALIGN:justify; MARGIN:5pt 0cm'><b><font style='FONT-SIZE:11pt; FONT-FAMILY:"Arial","sans-serif"' lang=EN-US>InFoods&#174;&nbsp;IBS is expected to address all IBS types that make up an approximate $30 billion market; up to 40 million Americans suffer from IBS </font></b></li></ul> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:windowtext; TEXT-ALIGN:justify; MARGIN:0cm 0cm 6pt 36pt; TEXT-INDENT:-18pt'><font style="FONT-SIZE:10pt; FONT-FAMILY:Symbol; COLOR:#002c40" lang=EN-US>&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font><b><font style='FONT-SIZE:11pt; FONT-FAMILY:"Arial","sans-serif"; COLOR:#002c40' lang=EN-US>Biomerica plans to meet with the FDA to review these results and finalize a pivotal trial for FDA clearance</font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:windowtext; MARGIN:0cm 0cm 6pt 36pt'><b><i></i></b>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:windowtext; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt'><font style="FONT-SIZE:10.5pt; FONT-FAMILY:Avenir; COLOR:#002c40" lang=EN-US>Irvine, California &#150; February 08, 2022 -- Biomerica, Inc. (Nasdaq: BMRA) (the &#147;Company&#148;) today announced positive topline results from the endpoint clinical trial of its InFoods&#174;&nbsp;IBS diagnostic-guided therapy (DGT), with the trial showing statistically significant improvements in multiple endpoints in the Intent-to-Treat population.<a name=_Hlk95152857> The InFoods&#174; DGT is the first of its kind therapy for Irritable Bowel Syndrome (IBS) that uses a simple blood test designed to identify patient-specific foods that when removed from the diet may alleviate IBS symptoms such as pain, bloating, diarrhea and constipation. </a>The InFoods&#174; IBS DGT works by identifying above normal immunoreactivity to specific foods in patients.&nbsp; A food identified as positive is simply removed from the diet for the patient to feel better.&nbsp;&nbsp; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:windowtext; TEXT-ALIGN:justify; MARGIN:12pt 0cm 6pt'><font style="FONT-SIZE:10.5pt; FONT-FAMILY:Avenir; COLOR:#002c40" lang=EN-US>The clinical trial was conducted by <a name=_Hlk92985796>Mayo Clinic, </a><a name=_Hlk92985761>Beth Israel Deaconess Medical Center Inc., a Harvard Medical School Teaching Hospital, Houston Methodist Hospital and the University of Michigan</a> among others.&nbsp; &nbsp;It was a double-blinded, randomized, placebo controlled clinical trial using the InFoods&#174;&nbsp;IBS therapy and was designed to select the optimal primary endpoint to be used in a pivotal trial to obtain FDA clearance.&nbsp; Based on this data showing statistically significant improvements in multiple endpoints, the Company will meet with the FDA to develop a final pivotal clinical trial which if positive would enable FDA clearance of its InFoods&#174; IBS DGT.&nbsp; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:windowtext; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:windowtext; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt'><font style="FONT-SIZE:10.5pt; FONT-FAMILY:Avenir; COLOR:#002c40" lang=EN-US>While multiple endpoints demonstrated statistically significant improvements in all patient subtypes in the study which included patients with <a name=_Hlk95154817>IBS-Constipation, IBS-Diarrhea &amp; IBS-Mixed</a>, the top line data showed patients diagnosed with IBS-Mixed and IBS-Constipation benefitted the most from the InFoods&#174; IBS Therapy. Biomerica finds this data very promising because there is currently no FDA cleared therapy for IBS-Mixed which accounts for roughly 33% of the approximate 40 million IBS sufferers in the United States. </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:windowtext; MARGIN:0cm 0cm 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:windowtext; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt' align=center><font style="FONT-SIZE:11.5pt; FONT-FAMILY:Avenir; COLOR:#002c40" lang=EN-US>1</font></p> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:windowtext; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt' align=center><b><font style="FONT-SIZE:11.5pt; FONT-FAMILY:Avenir; COLOR:#002c40" lang=EN-US> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></b></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:windowtext; MARGIN:0cm 0cm 0pt'><b><font style="FONT-SIZE:11.5pt; FONT-FAMILY:Avenir; COLOR:#002c40" lang=EN-US><img width=692 height=75 style="HEIGHT:75px; WIDTH:1089px" src=logo.jpg></font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:windowtext; MARGIN:0cm 0cm 0pt'><b><font style="FONT-SIZE:11.5pt; FONT-FAMILY:Avenir; COLOR:#002c40" lang=EN-US>Highlights of Topline Results from the InFoods&#174; IBS Endpoint Trial</font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:windowtext; MARGIN:0cm 0cm 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:windowtext; MARGIN:0cm 0cm 0pt 36pt; TEXT-INDENT:-18pt'><a name=_Hlk94707612><font style="FONT-SIZE:10.5pt; FONT-FAMILY:Symbol; COLOR:#002c40" lang=EN-US>&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style="FONT-SIZE:10.5pt; FONT-FAMILY:Avenir; COLOR:#002c40" lang=EN-US>P-value of 0.007 for improvement in the Subject Global Assessment of Relief (SGA) endpoint for all patient subtypes as a group (baseline vs 8 weeks)</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:windowtext; MARGIN:0cm 0cm 0pt 36pt; TEXT-INDENT:-18pt'><font style="FONT-SIZE:10.5pt; FONT-FAMILY:Symbol; COLOR:#002c40" lang=EN-US>&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style="FONT-SIZE:10.5pt; FONT-FAMILY:Avenir; COLOR:#002c40" lang=EN-US>P-value of 0.040 for improvement in the Global Improvement Scale (GIS) endpoint for all patient subtypes as a group (baseline vs 8 weeks)</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:windowtext; MARGIN:0cm 0cm 0pt 36pt; TEXT-INDENT:-18pt'><font style="FONT-SIZE:10.5pt; FONT-FAMILY:Symbol; COLOR:#002c40" lang=EN-US>&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style="FONT-SIZE:10.5pt; FONT-FAMILY:Avenir; COLOR:#002c40" lang=EN-US>P-value of 0.012 for improvement in the Pain endpoint for IBS-Mixed &amp; IBS-Constipation patients as a group (baseline vs 8 weeks)</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:windowtext; MARGIN:0cm 0cm 0pt 36pt; TEXT-INDENT:-18pt'><font style="FONT-SIZE:10.5pt; FONT-FAMILY:Symbol; COLOR:#002c40" lang=EN-US>&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style="FONT-SIZE:10.5pt; FONT-FAMILY:Avenir; COLOR:#002c40" lang=EN-US>P-value of 0.022 for improvement in the Bloating endpoint for IBS-Mixed &amp; IBS-Constipation patients as a group (baseline vs 8 weeks)</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:windowtext; MARGIN:0cm 0cm 6pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:windowtext; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt'><font style="FONT-SIZE:10.5pt; FONT-FAMILY:Avenir; COLOR:#002c40" lang=EN-US>Biomerica&#146;s Chairman and Chief Executive Officer Zack Irani stated, &#147;We are extremely excited about these results. IBS is a pervasive condition impacting the lives of well over 100 million patients worldwide. We are thrilled that this endpoint trial of InFoods&#174;&nbsp;IBS demonstrates a significant improvement in symptoms for IBS patients.&nbsp; Further, our platform can play a key role identifying the unique foods that may trigger or worsen symptoms in IBS patients, paving the way for a more effective therapy to alleviate patient suffering. We are now excited to embark on the final trial before submitting for FDA clearance. We&#146;re sincerely thankful for the key investigators at some of the most prestigious medical centers in the US, who helped us conduct the study and reach this milestone in the progression of the&nbsp;InFoods&#174;&nbsp;IBS program.&#148;</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:windowtext; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:windowtext; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt'><font style="FONT-SIZE:10.5pt; FONT-FAMILY:Avenir; COLOR:#002c40" lang=EN-US>Dr. Doug Drossman, President Emeritus of the Rome Foundation, Professor Emeritus in Medicine and Psychiatry at University of North Carolina, and Chairman of Biomerica&#146;s Scientific Advisory Board stated, &#147;We are encouraged and excited by these positive clinical trial results and look forward to assisting in the final pivotal trial phase.&nbsp; We believe the innovative InFoods&#174;&nbsp;IBS platform could provide physicians with a new way to treat patients and the data also suggests that this could be a key therapy for IBS-Mixed patients.&#148;&nbsp; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:windowtext; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:windowtext; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt'><font style="FONT-SIZE:10.5pt; FONT-FAMILY:Avenir; COLOR:#002c40" lang=EN-US>Dr. Brian Lacy, professor of medicine at Mayo Clinic and former co-Editor in Chief of the American Journal of Gastroenterology stated, &#147;We are excited about this trial and the results. This therapy would be a significant and important tool for physicians treating IBS patients especially those with mixed symptoms.&nbsp; In addition, this therapy can be used without or in conjunction with current pharmaceuticals, to potentially improve patient outcomes and revolutionize the way IBS is treated.&#148;</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:windowtext; MARGIN:0cm 0cm 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:windowtext; MARGIN:0cm 0cm 6pt'><b><font style="FONT-SIZE:11.5pt; FONT-FAMILY:Avenir; COLOR:#002c40" lang=EN-US>Next Steps</font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:windowtext; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt'><font style="FONT-SIZE:10.5pt; FONT-FAMILY:Avenir; COLOR:#002c40" lang=EN-US>With the positive outcome from this endpoint trial, Biomerica plans to meet and work with the FDA to design a final pivotal trial focused on the endpoint(s) that show the greatest improvement. The pivotal trial protocol is expected to be substantially similar to the completed endpoint trial, with a larger number of patients participating. At the same time Biomerica is in discussions about opportunities to commercialize the InFoods&#174; IBS DGT prior to FDA clearance as a Laboratory Developed Test service offered through a CLIA laboratory, and as a CE Marked product in Europe or other countries.&nbsp; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:windowtext; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:windowtext; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt'><font style="FONT-SIZE:10.5pt; FONT-FAMILY:Avenir; COLOR:#002c40" lang=EN-US>The InFoods&#174;&nbsp;IBS study design has already received a non-significant risk determination from FDA, which should expedite the final approval process. Since the InFoods&#174; IBS product is a diagnostic-guided therapy, and not a drug, it has no drug type side effects which benefits patients.&nbsp;&nbsp; &nbsp;&nbsp;</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:windowtext; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:windowtext; TEXT-ALIGN:justify; MARGIN:0cm 0cm 6pt'><font style="FONT-SIZE:10.5pt; FONT-FAMILY:Avenir; COLOR:#002c40" lang=EN-US>Biomerica plans to hold an R&amp;D day to discuss the full results in the next several months including the input and insights from key opinion leaders that were involved in the conduct of this trial. This will be part of a separate announcement.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:windowtext; TEXT-ALIGN:center; MARGIN:0cm 0cm 6pt' align=center><font style="FONT-SIZE:11.5pt; FONT-FAMILY:Avenir; COLOR:#002c40" lang=EN-US><br>2</font></p> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:windowtext; TEXT-ALIGN:center; MARGIN:0cm 0cm 6pt' align=center><b><font style="FONT-SIZE:11.5pt; FONT-FAMILY:Avenir; COLOR:#002c40" lang=EN-US> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></b></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:windowtext; MARGIN:0cm 0cm 0pt'><b><font style="FONT-SIZE:11.5pt; FONT-FAMILY:Avenir; COLOR:#002c40" lang=EN-US><img width=693 height=75 style="HEIGHT:75px; WIDTH:1086px" src=logo.jpg></font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:windowtext; MARGIN:0cm 0cm 0pt'><b><font style="FONT-SIZE:11.5pt; FONT-FAMILY:Avenir; COLOR:#002c40" lang=EN-US>About Biomerica (NASDAQ: </font></b><font lang=EN-US><b><font style="FONT-SIZE:11.5pt; TEXT-DECORATION:none; FONT-FAMILY:Avenir; COLOR:#002c40">BMRA</font></b></font><b><font style="FONT-SIZE:11.5pt; FONT-FAMILY:Avenir; COLOR:#002c40" lang=EN-US>) &nbsp;</font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:windowtext; MARGIN:0cm 0cm 0pt'><strong></strong>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:windowtext; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt'><font style="FONT-SIZE:10.5pt; FONT-FAMILY:Avenir; COLOR:#002c40" lang=EN-US>Biomerica, Inc. (www.biomerica.com) is a global biomedical technology company that develops, patents, manufactures and markets advanced diagnostic and therapeutic products used at the point of care (in home and in physicians' offices) and in hospital/clinical laboratories for detection and/or treatment of medical conditions and diseases. The Company's products are designed to enhance the health and well-being of people, while reducing total healthcare costs. Biomerica&#146;s primary focus is on gastrointestinal and inflammatory diseases where the Company has multiple diagnostic and therapeutic products in development.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:windowtext; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:windowtext; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt'><font style="FONT-SIZE:10.5pt; FONT-FAMILY:Avenir; COLOR:#002c40" lang=EN-US>The Private Securities Litigation Reform Act of 1995 provides a "safe harbor" for forward-looking statements. Certain information included in this press release (as well as information included in oral statements or other written statements made or to be made by Biomerica) contains statements that are forward-looking, such as statements relating to the efficacy of the Company&#146;s InFoods IBS DGT, clinical trial designs, meetings with the FDA, FDA clearance of the Company&#146;s InFoods IBS DGT product and commercialization of the Company&#146;s InFoods IBS DGT product. Such forward-looking information involves important risks and uncertainties that could significantly affect anticipated results in the future, including, without limitation: results of a final review the endpoint trial&#146;s data, the Company&#146;s ability to design and enroll patients in a pivotal trial for InFoods IBS DGT, delays in the anticipated timing of clinical trials, meeting with FDA, risks that the costs of a pivotal trial will exceed expectations, risks that a pivotal trial will not replicate the results of the Company&#146;s endpoint clinical trial, risks associated with the unpredictability of the regulatory approval process and the Company&#146;s ability to find a strategic partner to help commercialize its In Foods IBS DGT product. Accordingly, such results may differ materially from those expressed in any forward-looking statements made by or on behalf of Biomerica. Additionally, potential risks and uncertainties include, among others, fluctuations in the Company's operating results due to its business model and expansion plans, downturns in international and or national economies, the Company's ability to raise additional capital, the competitive environment in which the Company will be competing, and the Company's dependence on strategic relationships, and such other risks described in the Company&#146;s Annual Report on Form 10-K and other reports the Company files with the Securities and Exchange Commission from time to time. The Company is under no obligation to update any forward-looking statements after the date of this release.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:windowtext; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:windowtext; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt'><font style="FONT-SIZE:10.5pt; FONT-FAMILY:Avenir; COLOR:#002c40" lang=EN-US>&nbsp;</font><font style="FONT-SIZE:10.5pt; FONT-FAMILY:Avenir; COLOR:#002c40" lang=EN-US>Corporate Contact:</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:windowtext; MARGIN:0cm 0cm 0pt'><font style="FONT-SIZE:10.5pt; FONT-FAMILY:Avenir; COLOR:#002c40" lang=EN-US>John Nesbett /Jennifer Belodeau</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:windowtext; MARGIN:0cm 0cm 0pt'><font style="FONT-SIZE:10.5pt; FONT-FAMILY:Avenir; COLOR:#002c40" lang=EN-US>IMS Investor Relations</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:windowtext; MARGIN:0cm 0cm 0pt'><font style="FONT-SIZE:10.5pt; FONT-FAMILY:Avenir; COLOR:#002c40" lang=EN-US>203.972.9200</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:windowtext; MARGIN:0cm 0cm 0pt'><font lang=EN-US><font style="FONT-SIZE:10.5pt; TEXT-DECORATION:none; FONT-FAMILY:Avenir; COLOR:#002c40">jnesbett@institutionalms.com</font></font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:windowtext; MARGIN:0cm 0cm 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:windowtext; MARGIN:0cm 0cm 0pt'><font style="FONT-SIZE:10.5pt; FONT-FAMILY:Avenir; COLOR:#002c40" lang=EN-US>1&nbsp;Canavan et al. The epidemiology of irritable bowel syndrome Clin Epidemiol. 2014; 6: 71&#150;80. doi: 10.2147/CLEP.S40245</font></p> <br><p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:windowtext; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt' align=center><font style="FONT-SIZE:11.5pt; FONT-FAMILY:Avenir; COLOR:#002c40" lang=EN-US>3</font></p></div></body>
<!-- EDGAR Validation Code: C4DA0983 -->
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 logo.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0!:17AI9@  34T *@    @ !0,!  4
M   !    2@,#  $    !     %$0  $    ! 0   %$1  0    !     %$2
M  0    !             8:@  "QC__; $, " 8&!P8%" <'!PD)" H,% T,
M"PL,&1(3#Q0=&A\>'1H<'" D+B<@(BPC'!PH-RDL,#$T-#0?)SD].#(\+C,T
M,O_; $,!"0D)# L,& T-&#(A'"$R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,O_  !$( $L"LP,!(@ "$0$#$0'_
MQ  ?   !!0$! 0$! 0           0(#! 4&!P@)"@O_Q "U$  " 0,# @0#
M!04$!    7T! @, !!$%$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*"
M"0H6%Q@9&B4F)R@I*C0U-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS
M='5V=WAY>H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$
MQ<;'R,G*TM/4U=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$!
M 0$! 0$!         0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<
M 0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9
M&B8G*"DJ-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J"
M@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2
MT]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$  A$#$0 _ /?Z***
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M "BBB@ HHHH **** "BBB@ HHKF?&WBV+P=HZZA);?:2\RQ+%YFS.03G.#T
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M51U+4[32-/EOKZ80VT0'F.03@$@#@<Y)('%7 05!H =1249'J* %HI,CUI:
M"BBB@ HHHH **** "D[TM% #?I13J* $H[TM% #<4 8IU% #2.>M&*=12M8!
M.U%+13 ;S1VIU% 6(VX!."V!G&/Y5074Y2,#3+X_\!0?S:M.B@:=MS-^W79^
M[I=U_P ">,?^S&E%SJ)Z:>B_[\_^ -:-%&@[KL9W_$V<\+9Q ^K._P#04PV6
MHRGY]2$:^D$ !_\ 'MU:E% <S,.3PS:7 Q>W%[=@G[LMPP7_ +Y4@?I5JST3
M3-.4"ST^V@]XH@I/X]:TJ*!^TGM<8!@4X4M%! E**** "BBB@ HHHH ****
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M=V<YX_.C!QFEW'<\LL=;N+=(KW3]3N[Y8])FN-6>29I$CGV910I.V-]VX;%
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0ZTG:C'U_.@!:*;FBG8#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139689262656792">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document And Entity Information<br></strong></div></th>
<th class="th"><div>Feb. 08, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information Line Items</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">BIOMERICA, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BMRA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000073290<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Feb.  08,  2022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-37863<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">95-2645573<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">17571 Von Karman Ave<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Irvine<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92614<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">949<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">645-2111<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.08<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>bmra-20220208_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="bmra-20220208.xsd" xlink:type="simple"/>
    <context id="c0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
        </entity>
        <period>
            <startDate>2022-02-08</startDate>
            <endDate>2022-02-08</endDate>
        </period>
    </context>
    <dei:DocumentType contextRef="c0">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="c0">2022-02-08</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="c0">BIOMERICA, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c0">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="c0">001-37863</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="c0">95-2645573</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c0">17571 Von Karman Ave</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c0">Irvine</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c0">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c0">92614</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c0">949</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c0">645-2111</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="c0">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="c0">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="c0">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="c0">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="c0">Common Stock, par value $0.08</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c0">BMRA</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c0">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="c0">false</dei:EntityEmergingGrowthCompany>
    <dei:AmendmentFlag contextRef="c0">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="c0">0000073290</dei:EntityCentralIndexKey>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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MCMQC)8QQ8K3^-8+)#^Q^ %!+ P04    " "(@$I4.JJBYT !   \ @  #P
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M<F]P<R]A<' N>&UL4$L! A0#%     @ B(!*5&]'(!'M    *P(  !$
M         ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ B(!*
M5)E<G",0!@  G"<  !,              ( !RP$  'AL+W1H96UE+W1H96UE
M,2YX;6Q02P$"% ,4    " "(@$I46;0B(C4$  !'$   &
M@($,"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ B(!*
M5)^@&_"Q @  X@P   T              ( !=PP  'AL+W-T>6QE<RYX;6Q0
M2P$"% ,4    " "(@$I4EXJ[',     3 @  "P              @ %3#P
M7W)E;',O+G)E;'-02P$"% ,4    " "(@$I4.JJBYT !   \ @  #P
M        @ $\$   >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ B(!*5"0>
MFZ*M    ^ $  !H              ( !J1$  'AL+U]R96QS+W=O<FMB;V]K
M+GAM;"YR96QS4$L! A0#%     @ B(!*5&60>9(9 0  SP,  !,
M     ( !CA(  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&      D "0 ^ @
&V!,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>118</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="bmra-20220208.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biomerica.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="bmra-20220208.htm">bmra-20220208.htm</File>
    <File>bmra-20220208.xsd</File>
    <File>bmra-20220208_def.xml</File>
    <File>bmra-20220208_lab.xml</File>
    <File>bmra-20220208_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "bmra-20220208.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "definitionLink": {
     "local": [
      "bmra-20220208_def.xml"
     ]
    },
    "inline": {
     "local": [
      "bmra-20220208.htm"
     ]
    },
    "labelLink": {
     "local": [
      "bmra-20220208_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "bmra-20220208_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "bmra-20220208.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
      "https://xbrl.sec.gov/sic/2021/sic-2021.xsd"
     ]
    }
   },
   "elementCount": 25,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 118,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "bmra",
   "nsuri": "http://www.biomerica.com/20220208",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20220208.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000 - Document - Document And Entity Information",
     "role": "http://www.biomerica.com/role/DocumentAndEntityInformation",
     "shortName": "Document And Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20220208.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "bmra_DocumentAndEntityInformationAbstract": {
     "auth_ref": [],
     "localname": "DocumentAndEntityInformationAbstract",
     "nsuri": "http://www.biomerica.com/20220208",
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.biomerica.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.biomerica.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_DocumentInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "localname": "DocumentInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.biomerica.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "localname": "DocumentInformationTable",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.biomerica.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.biomerica.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.biomerica.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.biomerica.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.biomerica.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.biomerica.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.biomerica.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.biomerica.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.biomerica.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.biomerica.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.biomerica.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.biomerica.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.biomerica.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.biomerica.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.biomerica.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.biomerica.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.biomerica.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.biomerica.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.biomerica.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.biomerica.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.biomerica.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001513162-22-000014-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001513162-22-000014-xbrl.zip
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M,?]ZCR!V%&KRGE4FX9NPS$YE'W!M+5AH?M$PJ<K5>:-=/R*M=K5=;^UG\&4
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MY8O/LS  $\PXB6C9L'.6 3!U(X_00=GHMLU*N]IL&I\O 3BZ^,<T00-3S)#
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MM$0JI':U687H4.H!\DYR;()__*/U=7ZB=W3;>]N=,Q$P/)[Y%N7*: !9QI\
M;( 58B-L4A#1G-K OIGJD[EAZ\@"F=_N)P(6X.H@F8B(])2^-?@AD!K_)5 H
MQO'JIX>"@)]02P,$%     @ B(!*5%1VR^-6"   0%4  !4   !B;7)A+3(P
M,C(P,C X7VQA8BYX;6S=7%M3VSH0?C^_0B=]::<U=D);+@-T<@)A4D())*%
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M>0QA@D/E1<33\!B^&BV\I.4"-9 ]-BPMB[R5H3A'@D1,2<F2YR0U:/<VJ,(
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M0@3\(D+WN:Q\$^$@'. [YD=V83UFQ^."R0?/O^!)7/H?4$L#!!0    ( (B
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MP]+<"<S\5&8M8"'J/>NI2)3)H800/664G[YE#%^C/K[F%-_^!5!+ 0(4 Q0
M   ( (B 2E1>7?X%C!4  (6%   1              "  0    !B;7)A+3(P
M,C(P,C X+FAT;5!+ 0(4 Q0    ( (B 2E3J-WBL-P0  -4,   1
M      "  ;L5  !B;7)A+3(P,C(P,C X+GAS9%!+ 0(4 Q0    ( (B 2E1?
MWD!*WP4  /DI   5              "  2$:  !B;7)A+3(P,C(P,C X7V1E
M9BYX;6Q02P$"% ,4    " "(@$I45';+XU8(  ! 50  %0
M@ $S(   8FUR82TR,#(R,#(P.%]L86(N>&UL4$L! A0#%     @ B(!*5"WO
MIU^>!0  3"L  !4              ( !O"@  &)M<F$M,C R,C R,#A?<')E
:+GAM;%!+!08     !0 % $<!  "-+@     !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
